USPTO serial 79414786
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer software used in the context of drug discovery, diagnostics, genetics, proteomics and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals, pharmaceutical research; computer software used in the context of antibody discovery and identification; artificial intelligence software used in the context of drug discovery, affinity maturation, engineering of biological products, studies of molecular interactions, humanization and identification, drug research, antibody research and design, pharmaceutical research; machine learning software used in the context of drug discovery and identification, drug research, antibody research and design, pharmaceutical research; downloadable software for research, diagnostics, genomics, proteomics, omics and biological products; big data generating software. | SECTION 70 - CANCELLED | — |
| 042 | Software as a service [SaaS] for a use in the field of drug discovery, diagnostics, genetics, proteomics and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals, pharmaceutical research; medicine discovery services; biological research; scientific services and research in the field of drug discovery, affinity maturation, biological product engineering, studies of molecular interactions, humanization and identification, drug research, antibody, protein, peptide, biological and chemical research and design, pharmaceutical research; antibody sequencing; Research and development services related to AI in the field of drug discovery and identification, drug research, antibody research and design, pharmaceutical research; research and development in the field of drug discovery and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals; research and development services in the field of antibody technology; electronic data storage; Software as a Service [SaaS] including software for machine learning. | SECTION 70 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 9, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 15, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 15, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 10, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jun 13, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 24, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 24, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 27, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 26, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 20, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 17, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 16, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 16, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |